A Phase II Study of BVD-523 in Metastatic Uveal Melanoma
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Mayo Clinic
Fusion Pharmaceuticals Inc.
TriSalus Life Sciences, Inc.
Thomas Jefferson University
Turnstone Biologics, Corp.
Foghorn Therapeutics Inc.
Hoosier Cancer Research Network
Bellicum Pharmaceuticals
The Methodist Hospital Research Institute
Centre Antoine Lacassagne
Novartis
Polaris Group
Jonsson Comprehensive Cancer Center
Vanderbilt-Ingram Cancer Center
Wills Eye
Jonsson Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Radboud University Medical Center
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
M.D. Anderson Cancer Center
University of Southern California
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC